|
Changes in median expression and corresponding null probability values () for pair-wise comparison of disease classes and the non-fatigued control group for each individual gene in the CD19+ B cell Up-regulated gene set |
|||||||
| 3-Class (NF Controls) |
7-Class (Controls = LCA-0 U LCA-2) |
||||||
|
|
|
||||||
| Gene |
ISF |
CFS |
LCA-1 |
LCA-3 |
LCA-4 |
LCA-5 |
LCA-6 |
|
|
|
||||||
| SP140 |
-0.03 (0.60) |
0.02 (0.49) |
-0.07 (0.43) |
0.10 (0.60) |
0.01 (0.72) |
-0.08 (0.29) |
0.07 (0.92) |
| CD22 |
-0.16 (0.10) |
-0.09 (0.31) |
-0.14 (0.17) |
-0.58 (0.02) |
-0.30 (0.04) |
0.02 (0.35) |
0.05 (0.70) |
| QRSL1 |
-0.03 (0.95) |
-0.21 (0.91) |
0.29 (0.28) |
-0.10 (0.70) |
0.23 (0.50) |
-0.16 (0.89) |
-0.49 (0.42) |
| PTPRK |
-0.12 (0.55) |
-0.21 (0.18) |
-0.12 (0.76) |
-0.07 (0.82) |
-0.22 (0.68) |
-0.20 (0.17) |
-0.07 (0.64) |
| P2RY10 |
0.01 (0.21) |
-0.02 (0.51) |
0.08 (0.99) |
-0.08 (0.06) |
0.28 (0.82) |
0.11 (0.94) |
0.20 (0.33) |
| TSPAN3 |
-0.10 (0.54) |
-0.20 (0.19) |
-0.24 (0.39) |
-0.17 (0.83) |
0.13 (0.38) |
-0.08 (0.83) |
-0.02 (0.82) |
Aspler et al. Behavioral and Brain Functions 2008 4:44 doi:10.1186/1744-9081-4-44 |
|||||||